The course of long-term toxicity in patients treated with cisplatin- based chemotherapy for non-seminomatous germ-cell cancer

Annals of Oncology

Volumn 10, Issue 12, 1999, Pages 1475-1483

  Petersen, P M ^a   Hansen, S W ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Chemotherapy; Cisplatin; Long term toxicity; Testicular cancer

Indexed keywords

CISPLATIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CRYPTORCHISM; GERM CELL TUMOR; GLOMERULUS FILTRATION RATE; GONAD DYSFUNCTION; HUMAN; MALE; NEPHROTOXICITY; NEUROTOXICITY; NON SEMINOMATOUS GERMINOMA; ORCHIECTOMY; PARESTHESIA; PRIORITY JOURNAL; TESTIS CANCER;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CISPLATIN; FOLLICLE STIMULATING HORMONE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; INFERTILITY; LUTEINIZING HORMONE; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; PULMONARY DIFFUSING CAPACITY; SPERM COUNT; TESTICULAR NEOPLASMS; TESTOSTERONE; VINBLASTINE;

EID: 0033377259     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008322909836     Document Type: Article

References (54)

1. Adami H, Bergström R, Möhner M et al. Testicular cancer in nine Northern European countries. Int J Cancer 1994; 59: 33-8.
2. Væth M, Schultz HP, Von der Maase H et al. Prognostic factors in testicular germ-cell tumors. Experience from 1058 consecutive cases. Acta Radiol 1984; 23: 271-85.
3. Einhorn LH, Donohue J. Cis-diamminedichloroplatinuni, vinblastine, and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Intern Med 1977; 87: 293-8.
4. Roth BJ, Griest A, Kubilis PS et al. Cisplatin-based combination chemotherapy for disseminated germ-cell tumors: Long-term follow-up. J Clin Oncol 1988; 6: 1239-47.
5. Bokemeyer C, Berger CC, Kuczyk MA, Schmoll H-J. Evaluation of long-term toxicity after chemotherapy for testicular cancer. J Clin Oncol 1996; 14 (11): 2923-32.
6. Groth S, Nielsen H, Sørensen JB et al. Acute and long-term nephro-toxicity of cis-platinum in man. Cancer Chemother Pharmacol 1986; 17: 191-6.
7. Hansen SW, Groth S, Daugaard G et al. Long-term effects on ranal function and blood pressure of treatment with cisplatin, vinblastine, and bleomycin in patients with germ-cell cancer. J Clin Oncol 1988; 6: 1728-31.
8. Blum RH, Carter SK, Agre K. A clinical review of bleomycin - a new antineoplastic agent. Cancer 1973; 31: 903-13.
9. Comis RL. Detecting bleomycin pulmonary toxicity: A continued conundrum. J Clin Oncol 1990; 8: 765-7.
10. Sørensen PG, Rossing N, Rorth M. Carbon monoxide diffusing capacity: A reliable indicator of bleomycin-induced pulmonary toxicity. Eur J Respir Dis 1985; 66: 333-40.
11. Hansen SW, Groth S, Sørensen PG et al. Enhanced pulmonary toxicity in smokers with germ-cell cancer treated with cisplatin, vinblastine, and bleomycin: A long-term follow-up. Eur J Cancer Clin Oncol 1989; 25: 733-6.
12. Vogelzang NJ, Torkelson JL, Kennedy BJ. Hypomagnesemia, renal disfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastin. and bleomycin. Cancer 1985; 56: 2765-70.
13. Hansen SW, Olsen N, Rossing N, Rørth M. Vascular toxicity and the mechanism underlaying Raynaud's phenomenon in patients treated with cisplatin, vinblastin and bleomycin. Ann Oncol 1990; 1: 289-93.
14. Hansen SW, Olsen N. Raynaud's phenomenon in patients treated with cisplatin, vinblastin, and bleomycin for metastatic germ-cell cancer. J Gin Oncol 1989; 7: 940-2.
15. Hansen SW, Helweg-Larsen S, Trojaborg W. Long-term neurotoxicity in patients treated with cisplatin, vinblastine, and bleomycin for metastatic germ-cell cancer. J Clin Oncol 1989; 7: 1457-61.
16. Hansen SW. Autonom neuropathy after treatment with cisplatin, vinblastin, and bleomycin for germ-cell cancer. MBJ 1990; 300: 511-312.
17. Drasga RE, Einhorn LH, Williams SD. Fertility after chemotherapy for testicular cancer. J Clin Oncol 1983; 1 (3): 179-83.
18. Hansen PV, Trykker H, Andersen J, Helkjær PE. Germ-cell function and hormonal status in patients with testicular cancer. Cancer 1989; 64: 956-61.
19. Hansen SW, Berthelsen JG, von der Maase H. Long-term fertility and Leydig cell function in patients treated for germ-cell cancer with cisplatin, vinblastine, and bleomycin versus surveillance. J Clin Oncol 1990; 8: 1695-8.
20. Petersen PM, Hansen SW, Giwercman A et al. Dose-dependent impairment of testicular function in patients treated with cisplatin-based chemotherapy for germ-cell cancer. Ann Oncol 1994; 5: 355-8.
21. Palmieri G, Gotrecchiano G, Gicci G et al. Gonadal function after multimodality treatment in men with testicular germ-cell cancer. Eur J Endocrinol 1996; 134: 431-6.
22. Fosså SD, Ous S. Åbyholm T et al. Post-treatment fertility in patients with testicular cancer Br J Urol 1985; 57: 210-4.
23. Groth S, Aasted M. Cr-ETA clearance determined by one plasma sample. Clin Phys 1981; 1: 417-25.
24. Brøchner-Mortensen J, Rø P. Selection of routine method for determination of glomerular filtration rate in adult patients. Scan J Clin Lab Invest 1976; 36: 35-43.
25. Arterial hypertension. Report of an Expert Committee. Geneva: World Health Organization 1978.
26. Mitchell MM, Renzetti AD. Application of the single-breath method of total lung capacity measurement to the calculation of the carbon monoxide diffusing capacity. Am Rev Respir Dis 1968; 97: 581-4.
27. Ogilvie CM, Forster RE, Blakemore WS, Morton JW. A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. J Clin Invest 1957; 16: 1-17.
28. Dinakara P, Blumenthal WS, Johnston RF et al. The effect of anemia on pulmonary diffusing capacity with derivation of a correction equation. Am Rev Respir Dis 1970; 102: 965-9.
29. Groth S, Dirksen A, Dirksen H, Rossing N. Intraindividual variation and effect of learning in lung function examinations. A population study. Bull Eur Physiopathol Respir 1986; 22: 35-42.
30. Nielsen VK. The pherpheral nerve function in chronic failure. IV. An analysis of the vibration perception threshold. ACTA Med Scand 1972; 191: 287-96.
31. Levin AB. A simple test of cardiac function based upon the heart rate changes induced by the Valsalva maneuver. Am J Cardiol 1966; 18: 90-9.
32. Ewing DJ, Borsey DQ, Bellavere F, Clarke BF. Cardiac autonomic neuropathy in diabetes: Comparison of measure of R-R interval variation. Diabetologia 1981; 21: 18-24.
33. Ewing DJ, Clarke BF. Autonomic neuropathy: Its diagnosis and prognosis. Clin Endocrinol Metab 1986; 15: 855-88.
34. World Health Organization. WHO Laboratory Manual for the Examination of Human Semen and Semen-cervical Mucus Interaction. New York: Cambridge University Press 1987; 1-67.
35. World Health Organization. WHO Laboratory Manual for the Examination of Human Semen and Sperm-cervical Mucus Interaction. Cambridge: Cambridge University Press 1992.
36. Dentino M, Luft FC, Yum MN et al. Long-term effect of cis-diamminedichloride platinum (CDDP) on renal function and structure in man. Cancer 1978; 41: 1274-81.
37. Meijer S, Sleijfer DT, Mulder NH et al. Some effects of combination chemotherapy with cis-platinum on renal function in patients with nonseminomatous testicular carcinoma. Cancer 1983; 51: 2035-40.
38. Fjeldborg P, Sørensen J. Helkjær PE. The long-term effect of cisplatinum on renal function. Cancer 1986; 58: 2214-17.
39. Hamilton CR, Bliss JM, Horwich A. The late effects of cisplatinum on renal function. Eur J Cancer Clin Oncol 1989; 25: 185-9.
40. Levi JA, Thomson D, Sanderman T. A prospective study of cisplatin-based combination chemotherapy in advanced germ-cell malignancy: Role of maintenance and long-term follow-up. J Clin Oncol 1988; 6: 1154-60.
41. Felder RA, Holl RW, Martha P et al. Influence of matrix on concentrations of somatotropin measured in serum with commercial immunoradiometric assays. Clin Chem 1989; 35: 1423-6.
42. Barneveld PWC, Veenstra G, Sleijfer DT et al. Changes in pulmonary function during and after bleomycin treatment in patients with testicular cacinonia. Cancer Chemotgher Pharmacol 1985; 14: 168-71.
43. Goldiner PL, Carlon GC, Cvitkovic E et al. Factors influencing postoperative morbidity and mortality in patients trested with bleomycin. BMJ 1978; 1: 1664-7.
44. Hamilton D, Williams M, Wilmhurst P. The bends. BMJ 1988; 297: 793-4.
45. Zanetti CL. Scuba diving and the bleomycin therapy. JAMA 1990; 264: 2869.
46. Cowan JD, Kies MS, Roth JL, Joyce RP. Nerve conduction studies in patients treated with cisdiamminedichloroplatium (II): A preliminary report. Cancer Treat Rep 1980; 64; 1119-22.
47. Thompson SW, Davis LE, Kornfeld M et al. Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies. Cancer 1984; 54: 1269-75.
48. Ongerboer-de-Visser BW, Tiesens G. Polyneuropathy induced by cisplatin. Prog ExpTumor Res 1985; 29: 190-6.
49. Kaplan RS, Wiernik PH. Neurotoxicity of antineoplasticdrugs. Semin Oncol 1982; 9: 103-30.
50. Roelofs RI, Hruskesky W, Rogin J et al. Peripheral sensory neuropathy and cisplatin chemotherapy. Neurology 1984; 34: 934-8.
51. Riggs JE, Ashraf M, Snyder RD et al. Prospective nerve conduction studies.
52. Petersen PM, Skakkebæk NE, Rørth M, Giwercman A. Semen quality and reproductive hormones before orchiectomy in men with testicular cancer. J Clin Oncol 1999; 17 (3): 941-7.
53. Meistrich ML, Chawla SP, Da Cunha F et al. Recovery of sperm production after chemotherapy for osteosarcoma. Cancer 1989; 62: 2115-23.
54. Hansen PV, Trykker H, Helkjær PE, Andersen J. Testicular function in patients with testicular cancer treated with orchiectomy alone or orchiectomy plus cisplatin-based chemotherapy. J Natl Cancer Inst 1989; 81: 1246-50.